Scienture Holdings, Inc. (SCNX)
NASDAQ: SCNX · Real-Time Price · USD
0.9625
-0.0775 (-7.45%)
At close: Apr 4, 2025, 4:00 PM
0.9428
-0.0197 (-2.04%)
After-hours: Apr 4, 2025, 7:59 PM EDT

Scienture Holdings Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Revenue
0.141.360.3
Revenue Growth (YoY)
-89.98%354.61%-
Cost of Revenue
0.131.31-
Gross Profit
0.010.050.3
Selling, General & Admin
12.474.450.88
Research & Development
2.24-3.06
Operating Expenses
14.714.453.94
Operating Income
-14.7-4.4-3.64
Interest Expense
-1.34-1.14-0.08
Interest & Investment Income
0.140-
Other Non Operating Income (Expenses)
-0-0.150.01
EBT Excluding Unusual Items
-15.9-5.68-3.71
Gain (Loss) on Sale of Investments
-2.5--
Gain (Loss) on Sale of Assets
-0.37-2.8-
Pretax Income
-18.78-8.48-3.71
Income Tax Expense
-0.53--
Earnings From Continuing Operations
-18.24-8.48-3.71
Earnings From Discontinued Operations
27.31-9.36-
Net Income
9.07-17.84-3.71
Net Income to Common
9.07-17.84-3.71
Shares Outstanding (Basic)
315
Shares Outstanding (Diluted)
315
Shares Change (YoY)
341.76%-84.72%-
EPS (Basic)
2.69-23.35-0.74
EPS (Diluted)
2.68-23.35-0.74
Free Cash Flow
-14.28-2.23-3.35
Free Cash Flow Per Share
-4.23-2.91-0.67
Gross Margin
4.40%3.60%100.00%
Operating Margin
-10758.70%-322.36%-1213.87%
Profit Margin
6634.66%-1308.34%-1236.13%
Free Cash Flow Margin
-10448.57%-163.16%-1117.56%
EBITDA
-14.7-3.56-
EBITDA Margin
--261.20%-
D&A For EBITDA
00.83-
EBIT
-14.7-4.4-3.64
Updated Nov 6, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q